Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
410 W 10th Ave
Columbus, OH 43210Phone+1 614-293-5066Fax+1 614-293-9469
Education & Training
- University at BuffaloFellowship, Hematology and Medical Oncology, 2018
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2012 - 2015
- Tongji Medical UniversityClass of 2005
Certifications & Licensure
- OH State Medical License 2019 - 2025
- NY State Medical License 2015 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Futibatinib in Combination with Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy Start of enrollment: 2024 Dec 30
Roles: Contact, Sponsor-Investigator, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsImpact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP).Shawn Dason, Rajvi Goradia, Victor Heh, Akshay Sood, Matthew Lee
Clinical Genitourinary Cancer. 2025-02-01 - Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches.Adam Khorasanchi, Feng Hong, Yuanquan Yang, Eric A Singer, Peng Wang
Cancer Drug Resistance. 2025-01-01 - Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.Adam Khorasanchi, Karan Jatwani, Lingbin Meng, Katharine A Collier, Debasish Sundi
Cancers. 2024-12-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: